A recent study [101] has shown that citral can inhibit the expression of pro-IL-1β mediated by endotoxin and the activation of the NLRP3 inflammasome mediated by ATP, which is intriguing for the treatment of SLE. Here, NLRP3 is linked to systemic lupus erythematosus.